Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Bleeding Incidence Among Patients With Venous Thromboembolism: A Large US Insurance Database Analysis

Xianchen Liu, MD, PhD, Lin Xie, MS, Hemant Phatak, PhD, Jack Mardekian, PhD, Wilson Tan, MD, Onur Baser, PhD, Eduardo Ramacciotti, M.D., Ph.D.

Blood (2013) 122 (21): 2916.

https://doi.org/10.1182/blood.V122.21.2916.2916

Published: 2013

Journal Articles

Pharmacologic Prophylaxis for Venous Thromboembolism Among Hospitalized Patients with Acute Medical Illness: An Electronic Medical Records Study

Marc B Rosenman, MD, Xianchen Liu, MD, PhD, Hemant Phatak, PhD, Amy Qi, Evgenia Teal, Daniel Nisi, Larry Z Liu, MD, PhD, Eduardo Ramacciotti, M.D., Ph.D.

Blood (2011) 118 (21): 2074.

https://doi.org/10.1182/blood.V118.21.2074.2074

Published: 2011

Journal Articles

An Open Label, Non Randomized, Propspective Phase IV Clinical Trial Evaluating the Immunogenicity of Branded Enoxaparin Versus Biosimilars In Healthy Volunteers.

Marise Gomes, Ph.D., Eduardo Ramacciotti, M.D., Ph.D., Debra Hoppensteadt, Ph.D., Jeanine M. Walenga, PhD, Bruce E Lewis, MD, Walter Jeske, Ph.D., Jawed Fareed, PhD

Blood (2010) 116 (21): 1086.

https://doi.org/10.1182/blood.V116.21.1086.1086

Published: 2010

Journal Articles

Protease Generation by Chondroitin Sulfate, Semisynthetic OSCS Preparations and Contaminants Isolated From Heparin.

Melanie Clark, Nasir Sadeghi, Debra Hoppensteadt, Lauren Myers, Vinod Bansal, Eduardo Ramacciotti, M.D., Ph.D., Jawed Fareed

Blood (2009) 114 (22): 3133.

https://doi.org/10.1182/blood.V114.22.3133.3133

Published: 2009

Journal Articles

Contaminants Isolated From Recalled Heparin Are Not All the Same: Clinical Implications.

Jawed Fareed, Melanie Clark, Vinod Bansal, Lauren Myers, Omer Iqbal, MD, Debra Hoppensteadt, Eduardo Ramacciotti, M.D., Ph.D., Jeanine M. Walenga, PhD

Blood (2009) 114 (22): 1069.

https://doi.org/10.1182/blood.V114.22.1069.1069

Published: 2009

NARROW

Bleeding Incidence Among Patients With Venous Thromboembolism: A Large US Insurance Database Analysis

Pharmacologic Prophylaxis for Venous Thromboembolism Among Hospitalized Patients with Acute Medical Illness: An Electronic Medical Records Study

An Open Label, Non Randomized, Propspective Phase IV Clinical Trial Evaluating the Immunogenicity of Branded Enoxaparin Versus Biosimilars In Healthy Volunteers.

Protease Generation by Chondroitin Sulfate, Semisynthetic OSCS Preparations and Contaminants Isolated From Heparin.

Contaminants Isolated From Recalled Heparin Are Not All the Same: Clinical Implications.

Email alerts

ASH Publications

American Society of Hematology

Bleeding Incidence Among Patients With Venous Thromboembolism: A Large US Insurance Database Analysis

Pharmacologic Prophylaxis for Venous Thromboembolism Among Hospitalized Patients with Acute Medical Illness: An Electronic Medical Records Study

An Open Label, Non Randomized, Propspective Phase IV Clinical Trial Evaluating the Immunogenicity of Branded Enoxaparin Versus Biosimilars In Healthy Volunteers.

Protease Generation by Chondroitin Sulfate, Semisynthetic OSCS Preparations and Contaminants Isolated From Heparin.

Contaminants Isolated From Recalled Heparin Are Not All the Same: Clinical Implications.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only